Future advancements in undereye voluminization? Is regenerative med hype or substantiated?

Question

I'm curious about correcting undereye hollowing, where the contours of the orbital rim become visible. To my knowledge, the primary options are hyaluronic acid filler, fat grafting, and surgical approaches such as lower blepharoplasty with fat repositioning. I was curious whether you see any emerging treatments or technologies that show promise in this area. Additionally, do regenerative therapies such as PRP, PDGF, exosomes, or other biologics have sufficient evidence supporting tear trough voluminization, or is much of the enthusiasm currently ahead of the evidence? Or is it reasonable application based on therapeutic mechanism?

Anna Chacon, MD, FAAD · Answer

The tear trough and undereye area remain some of the most challenging regions to treat aesthetically. You're correct that our current gold-standard options for true volume restoration are still hyaluronic acid fillers, fat grafting, and surgical approaches such as lower blepharoplasty with fat repositioning. Each addresses volume loss differently, and each has advantages and limitations depending on anatomy and age-related changes.

When I look at the future of undereye rejuvenation, I think we're moving away from simply "filling a hollow" and toward restoring the entire tissue environment. The ideal treatment would not only replace lost volume but also improve skin quality, support collagen production, enhance vascular health, and maintain a natural appearance over time.

What Looks Most Promising?

One area generating significant interest is regenerative fat grafting. Rather than transferring fat alone, researchers are investigating ways to enrich fat grafts with adipose-derived stem cells or stromal vascular fraction. The goal is to improve graft survival while also enhancing tissue quality. Early data are encouraging, but protocols remain variable, and long-term outcomes are still being studied.

Biostimulatory injectables are another area of interest. Products that stimulate collagen production may eventually play a larger role in the periorbital region, although the undereye area is delicate and less forgiving than other parts of the face. Safety remains paramount, and many of these products require cautious use around the eyes.

We are also seeing advances in imaging, ultrasound-guided injections, and personalized treatment planning, which may make existing treatments safer and more precise than ever before.

What About PRP, Exosomes, PDGF, and Other Biologics?

This is where the conversation becomes more nuanced.

From a biological standpoint, the rationale is appealing. Platelet-rich plasma (PRP), growth factors, and exosome-based therapies contain signaling molecules that may promote tissue repair, collagen synthesis, and improved skin quality. Mechanistically, the concept makes sense.

However, when we specifically ask whether these therapies reliably create meaningful tear trough voluminization, the evidence becomes much less convincing.

In my view:

PRP has the strongest evidence among the regenerative options currently available. It may improve skin texture, fine lines, crepiness, and overall skin quality around the eyes. However, it generally does not produce the degree of volume restoration that fillers or fat transfer can achieve.
PDGF-based therapies show promise in wound healing and tissue regeneration, but data specifically supporting significant undereye volume correction remain limited.
Exosomes generate tremendous excitement, but the clinical evidence is still immature. There are many theoretical benefits and encouraging laboratory findings, yet high-quality human studies demonstrating reliable, reproducible tear trough volumization are lacking.
Other biologics and stem-cell-derived products are similarly intriguing but remain ahead of the evidence in many cases.
Is the Enthusiasm Ahead of the Science?

I would say the answer is both yes and no.

The enthusiasm is not entirely hype because these therapies are grounded in legitimate biological mechanisms. We know growth factors, cytokines, and regenerative signaling pathways play important roles in tissue repair and aging.

Where the hype can outpace reality is when regenerative treatments are marketed as direct replacements for established volume-restoring procedures. At this time, the evidence does not support viewing PRP, exosomes, or similar biologics as substitutes for filler, fat grafting, or surgery when true structural hollowing is the primary concern.

Instead, I view regenerative therapies as potentially complementary. They may improve skin quality, healing, and tissue health while traditional volume-restoring treatments address the actual contour deficit.

My Current Perspective

If the goal is to correct visible orbital rim hollowing, today's most predictable options remain hyaluronic acid filler in carefully selected patients, fat grafting, and surgical fat repositioning when indicated. Regenerative therapies are exciting and may become increasingly important in the coming years, but for now they are best viewed as adjunctive tools rather than definitive solutions for significant tear trough volume loss.

The future likely belongs to treatments that combine structural restoration with true tissue regeneration. We're not fully there yet, but the field is moving in that direction, and it's one of the most fascinating areas of aesthetic medicine to watch.

Nelson Lee Novick, MD · Answer

The short answer to your question about emerging technologies is that, at least for the present, their use remains far more backed by social media buzz than any hard science. So, kudos to you that you questioned whether the current enthusiasm outpaces the hard science. 
As to fat grafting, besides being expensive and requiring a two-step somewhat invasive procedure (harvesting the fat from location and transplanting it to the under eyes with large bore cannulas), there are other issues to consider.. While it is enticing to think that because your own fat is being auto transplanted that it will be a one-and-done procedure. Unfortunately, the fact is that much of the transplanted fat when separated from its original blood supply may actually not survive, What's more the fat that does manage to survive retains the characteristics of the location from which it is taken--meaning that if it is taken from belly, for example, when, with aging, the belly fat takes on the "midriff bulge," so, too, can the belly fat transplanted under the eyes. Not a happy scenario.
Surgery of course, besides being expensive, carries with it post-operative downtime and the risks of scarring. Additionally, surgery may also not be a one and done solution, since surrounding age-related changes in the skin, fat, and connective can turn a once satisfactory result into an unsatisfactory one with the passage of time.
Appropriately selected and properly injected hyaluronic acid fillers, on the other hand,  can work well for immediately improving under-eye hollows and tear troughs and can also be relatively easily dissolved should the need arise. 
You would be wise to consult with an experienced, board certified cosmetic dermatologist filler injector expert to investigate this further and best of luck.

Future advancements in undereye voluminization? Is regenerative med hype or substantiated?

Answers (2)

More Dermal Fillers Questions

40 years old, previous lip filler 3 years ago. Left side of mouth is weird - lip filler migration? (Photo)

33, chubby lower face - What can I do to make the lower third of my face more sculpted? (Photos)

Knee skin rejuvenation - would filler be helpful for this area? (Photos)

What is the future of under-eye treatments?

Can I dye my goatee after nasolabial fillers?

What procedures would improve my face? (Photos)

WE SEND PRETTY
EMAILS